Alicia Grande - 17 Aug 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
VP, Treasurer and CFO
Signature
/s/ Alicia Grande
Issuer symbol
CPRX
Transactions as of
17 Aug 2022
Net transactions value
-$1,695,983
Form type
4
Filing time
19 Aug 2022, 17:02:34 UTC
Previous filing
16 Feb 2022
Next filing
30 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $251,269 +99,316 +21% $2.53* 574,853 17 Aug 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $1,375,745 -99,316 -17% $13.85 475,537 17 Aug 2022 Direct F1, F3
transaction CPRX Common stock, par value $0.001 per share Options Exercise $79,505 +31,425 +6.6% $2.53* 506,962 17 Aug 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $435,890 -31,425 -6.2% $13.87 475,537 17 Aug 2022 Direct F2, F3
transaction CPRX Common Stock, par value $0.001 per share Options Exercise $48,725 +19,259 +4% $2.53* 494,796 18 Aug 2022 Direct
transaction CPRX Common Stock, par value $0.001 per share Sale $263,848 -19,259 -3.9% $13.70 475,537 18 Aug 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -99,316 -6.6% $0.000000 1,408,351 17 Aug 2022 Common Stock 99,316 $2.53 Direct F4
transaction CPRX Options to purchase common stock Options Exercise $0 -31,425 -2.2% $0.000000 1,376,926 17 Aug 2022 Common Stock 31,425 $2.53 Direct F4
transaction CPRX Options to purchase common stock Options Exercise $0 -19,259 -1.4% $0.000000 1,357,667 18 Aug 2022 Common Stock 19,259 $2.53 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold in various lots from $13.85 to $13.88 per share. The listed sale price represents a weighted average price for the shares sold.
F2 Shares were sold in various lots from $13.87 to $13.88 per share. The listed sale price represents a weighted average price for the shares sold.
F3 Shares were sold to cover exercise price of options, tax withholding requirements (if applicable) and for personal reasons. Shares were not sold as a result of any disagreement with the Company and Ms. Grande remains an officer of the Company.
F4 Options vested in three annual tranches beginning on December 30, 2016.